Multiomics Services Market Trends Support A 20.1% CAGR Outlook Through The Forecast Period

The multiomics services sector is positioned for remarkable expansion in the coming years, driven by the increasing importance of integrating various biological data types. As researchers and pharmaceutical companies continue to seek deeper insights into complex biological systems, this market is evolving rapidly, embracing cutting-edge technologies and innovative applications.

Growth Outlook and Market Size for Multiomics Services by 2030
The multiomics services market is predicted to grow substantially, reaching a valuation of $3.56 billion by 2030. This growth reflects a strong compound annual growth rate (CAGR) of 20.1%. Key factors contributing to this rise include the wider adoption of precision medicine methodologies, increased investment by pharmaceutical firms into systems biology, the broadening use of multiomics in drug discovery, and the integration of artificial intelligence for interpreting biological data. Additionally, demand is surging for personalized therapeutic development. Noteworthy trends anticipated throughout the forecast period involve greater use of integrated multiomics platforms, heightened interest in single-cell multiomics services, the proliferation of data-driven biological insights, expansion of cloud-based omics data integration capabilities, and a growing emphasis on translational research applications.

The multiomics services market size has grown exponentially in recent years. It will grow from $1.42 billion in 2025 to $1.71 billion in 2026 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to growth in genomics and proteomics research activities, expansion of academic and clinical research funding, increasing availability of high-throughput sequencing technologies, rising collaboration between research institutions, advancements in bioinformatics tools.

Download a free sample of the multiomics services market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27355&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Top Companies Leading the Multiomics Services Market
A number of influential players are currently shaping the multiomics services landscape. These include Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., and Clinical Microbiomics A/S.

Strategic Acquisition Enhancing Multiomics Capabilities
In a notable industry move, Bruker Corporation, a U.S.-based firm specializing in scientific instruments and analytical solutions, acquired Biocrates Life Sciences AG in June 2025. The financial terms were not disclosed. This acquisition aims to strengthen Bruker's multiomics approach by combining Biocrates' advanced metabolomics and lipidomics technologies with Bruker's existing proteomics capabilities. Biocrates Life Sciences AG, based in Austria, is renowned for its expertise in multiomics services, making this collaboration a strategic fit.

View the full multiomics services market report:
https://www.thebusinessresearchcompany.com/report/multiomics-services-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Innovations and Future Directions in Multiomics Services
Leading companies in the multiomics services field are emphasizing the development of novel techniques, such as 3D genome mapping, to advance understanding of gene regulation, disease mechanisms, and tailored treatment options. 3D genome mapping involves analyzing the spatial arrangement of the genome within the nucleus, offering deeper biological insights. For example, in January 2025, UK biotechnology firm Enhanc3D Genomics introduced a comprehensive suite of 3D multiomics tools designed to accelerate drug discovery and improve precision. Their platform uniquely integrates genome-wide regulatory interaction data with multiomics profiles in a single assay, enabling detailed views of gene regulation. The proprietary Promoter Capture Hi-C technology allows exact mapping of long-range regulatory interactions, including those in non-coding regions. The platform also features modular components-GenLinkConnect, GenLinkResponse, and GenLinkProfile-for SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling, respectively. Additionally, GenLinkHub software offers a user-friendly interface for 3D visualization, data management, and quality assurance, supporting researchers in interpreting complex datasets more effectively.

Detailed Market Segmentation for Multiomics Services
This report categorizes the multiomics services market into several segments:
1) By Type: Single-Cell Multiomics and Bulk Multiomics
2) By Application: Biomarker Discovery, Drug Discovery and Development, Synthetic Biology, and Other Applications
3) By End Users: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Other End Users

Further breakdowns include:
- For Single-Cell Multiomics: Single-Cell Genomics Services, Single-Cell Transcriptomics Services, Single-Cell Proteomics Services, and Single-Cell Epigenomics Services
- For Bulk Multiomics: Genomics and Transcriptomics Integration Services, Genomics and Proteomics Integration Services, Transcriptomics and Proteomics Integration Services, and Epigenomics and Transcriptomics Integration Services

These detailed categories highlight the diverse applications and service types within the multiomics sector, reflecting its growing complexity and specialization.

Our 2026 market reports now include enhanced strategic insights through:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.